Comments on hyperbaric oxygen and carbogen/nicotinamide with fractionated radiation.
作者信息
Brown J M, Wouters B G
出版信息
Radiat Res. 1997 Nov;148(5):526-7.
PMID:9355876
Abstract
摘要
相似文献
1
Comments on hyperbaric oxygen and carbogen/nicotinamide with fractionated radiation.
Radiat Res. 1997 Nov;148(5):526-7.
2
3
Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response?
Radiat Res. 1997 Nov;148(5):523-5.
4
Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.
Radiat Res. 1997 Jun;147(6):715-20.
5
Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Radiother Oncol. 2004 Mar;70(3):301-9. doi: 10.1016/j.radonc.2004.01.017.
6
The potential for improving radiotherapy outcome by improving the oxygen supply to solid tumours.
Strahlenther Onkol. 1996 Nov;172 Suppl 2:22-3.
7
ARCON.
Clin Oncol (R Coll Radiol). 1994;6(5):281-2. doi: 10.1016/s0936-6555(05)80266-3.
8
Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.
J Clin Oncol. 2010 Nov 20;28(33):4912-8. doi: 10.1200/JCO.2010.28.4950. Epub 2010 Oct 18.
9
Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
Radiat Oncol Investig. 1999;7(3):163-9. doi: 10.1002/(SICI)1520-6823(1999)7:3<163::AID-ROI5>3.0.CO;2-M.
10
Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
Radiother Oncol. 1996 Apr;39(1):53-64. doi: 10.1016/0167-8140(95)01678-3.
Zotero 插件